Related Experiment Video
Updated: Sep 28, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
Published on: September 20, 2024
[Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia]
S. Migliaresi1, G. Di Iorio, A. Ammendola
1Istituto di Clinica Medica, Cattedra di Reumatologia, Seconda Università degli Studi di Napoli, Italy. sergio.migliaresi@unina2.it
Abstract:
In HCV-related mixed cryoglobulinemia (MC) a peripheral neuropathy (PN) may occur. To evaluate the prevalence and the characteristics of PN, 133 consecutive patients with HCV-MC (117 type II, 16 type III) were studied. Neurologic evaluation was performed according to the guidelines of Italian Group for the Study of Cryoglobulinemias, using a neurological disability score and a neurological symptom score. In 52/133 patients an electrophysiologic study (ENG) of ulnar, peroneal and sural nerves was performed. For 27/52 patients ENG data registered at different times (interval 12-96 months) were available. In 11 patients a sural nerve biopsy was obtained. An overt PN, mostly as sensory asymmetrical or symmetrical nerve impairment, was found in 107/133 patients (80.4%). ENG abnormalities-reduction or absence of sensory and sometimes of motor action potential, normal or slightly impaired nerve conduction velocity, consistent with axonal damage- were detected in 48/52 patients (92.3%). In 26 out of the 27 patients observed at different times an evolution of PN was found. Nerve biopsies showed a prevalent axonal damage, swollen endothelial cells in epi- and perineurial vessels and scarce mononuclear perivascular infiltrates. No leukocytoclastic vasculitis was observed. Immunoglobulins and complement in sub-perineurial vessel wall were detected. CONCLUSIONS: In HCV-MC a PN is frequent. It is mostly a sensory and progressively worsening axonopathy. Different mechanisms may be involved in the pathogenesis of this disorder and a direct role of HCV cannot be excluded.
Insights
Hepatitis C Virus (HCV)-related mixed cryoglobulinemia frequently causes peripheral neuropathy (PN). This progressive sensory axonopathy, often worsening over time, impacts nerve function and requires further study into its pathogenesis.
Area of Science:
- Neurology
- Immunology
- Hepatology
Background:
- Hepatitis C Virus (HCV)-related mixed cryoglobulinemia (MC) is associated with peripheral neuropathy (PN).
- Understanding the prevalence and characteristics of PN in HCV-MC patients is crucial for diagnosis and management.
Purpose of the Study:
- To determine the prevalence and clinical/electrophysiological characteristics of peripheral neuropathy in patients with HCV-related mixed cryoglobulinemia.
- To investigate the progression and pathological features of PN in this patient cohort.
Main Methods:
- Prospective study of 133 consecutive patients with HCV-MC.
- Neurological evaluation using disability and symptom scores.
- Electrophysiologic studies (ENG) and sural nerve biopsies in a subset of patients.
- Longitudinal follow-up ENG data for 27 patients.
Main Results:
- Overt peripheral neuropathy was diagnosed in 80.4% of patients (107/133).
- Electrophysiologic studies revealed axonal damage in 92.3% of patients with abnormalities (48/52).
- Progressive neuropathy was observed in 26/27 patients with longitudinal data.
- Nerve biopsies indicated prevalent axonal damage and vasculopathy affecting small vessels.
Conclusions:
- Peripheral neuropathy is a frequent complication of HCV-related mixed cryoglobulinemia.
- The condition is primarily a sensory, progressive axonopathy.
- Pathogenesis may involve multiple mechanisms, with a potential direct role of HCV.
Related Concept Videos
Hepatitis
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Hypersensitivity Reactions: Immune-Complex Reactions
Viral Hepatitis I: Introduction
Hypersensitivity Reactions: Cytolytic Reactions

